James E. Krause

Keine laufenden Positionen mehr

72 Jahre

Health Technology

Consumer Services

Ehemalige bekannte Positionen von James E. Krause

Unternehmen	Position	Beginn	Ende
Washington University in St. Louis	Corporate Officer/Principal	01.01.1997	01.01.1997
ARMGO Pharma, Inc. ARMGO Pharma, Inc. Pharmaceuticals: MajorHealth Technology ARMGO Pharma, Inc. discovers and develops novel small-molecule therapeutics. Its product include Rycal Science is an inspiring new direction in therapy for the leading causes of morbidity and mortality; Rycals are small-molecule therapeutics developed in the laboratory. The company was founded in 2004 and is headquartered in New York, NY.	Technik-/Wissenschafts-/F&E-Leiter	05.11.2009	-
Neurogen Corp. Neurogen Corp. Pharmaceuticals: MajorHealth Technology Neurogen Corp. operated as a drug discovery and development company. The company was headquartered in Branford, CT.	Corporate Officer/Principal	01.01.1997	-

University of Wisconsin

Doctorate Degree

International

Vereinigte Staaten

Operativ

Corporate Officer/Principal	2
Doctorate Degree	1
Undergraduate Degree	1

Sektoral

Health Technology	3
Consumer Services	3

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Private Unternehmen	2
Neurogen Corp. Neurogen Corp. Pharmaceuticals: MajorHealth Technology Neurogen Corp. operated as a drug discovery and development company. The company was headquartered in Branford, CT.	Health Technology
ARMGO Pharma, Inc. ARMGO Pharma, Inc. Pharmaceuticals: MajorHealth Technology ARMGO Pharma, Inc. discovers and develops novel small-molecule therapeutics. Its product include Rycal Science is an inspiring new direction in therapy for the leading causes of morbidity and mortality; Rycals are small-molecule therapeutics developed in the laboratory. The company was founded in 2004 and is headquartered in New York, NY.	Health Technology

Private Unternehmen

Health Technology